RA: Lung Disease Risk Tracks Biomarkers (CME/CE)
(MedPage Today) -- Standard RA biomarkers appear to raise risk of interstitial lung disease (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 24, 2015 Category: Geriatrics Source Type: news
Baseline CT scans predict lung fibrosis in SSc
Patients with newly diagnosed systemic sclerosis should have a high-resolution lung CT and pulmonary function tests, because when assessed together, their findings identify patients at high risk of interstitial lung disease, researchers say.
In a study of 305 patients with systemic sclerosis... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 2, 2015 Category: Dermatology Tags: CME-candidate IMN News RHEUM News RHEUM Lupus/Connective Tissue Diseases CHEST Pulmonary Medicine CHEST Clinical News CHEST News FPN News Source Type: news
Interstitial Lung Disease
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 22, 2015 Category: Journals (General) Source Type: news
Interstitial Lung Disease in Systemic SclerosisInterstitial Lung Disease in Systemic Sclerosis
How often should systemic sclerosis patients be screened for interstitial lung disease? Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 3, 2015 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Nintedanib Slows Fibrosing Interstitial Lung Disease
Nintedanib linked to lower rate of decline in forced vital capacity versus placebo in phase 3 trial (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, Conference News, Source Type: news
Interstitial lung disease is significant risk factor for lung inflammation
Pretreatment interstitial lung disease is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy alone, researchers say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2014 Category: Science Source Type: news
Interstitial Pneumonitis (Interstitial Lung Disease)
Title: Interstitial Pneumonitis (Interstitial Lung Disease)Category: Diseases and ConditionsCreated: 11/10/2014 12:00:00 AMLast Editorial Review: 11/10/2014 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 10, 2014 Category: Respiratory Medicine Source Type: news
Interstitial Lung Disease (Interstitial Pneumonitis)
Title: Interstitial Lung Disease (Interstitial Pneumonitis)Category: Diseases and ConditionsCreated: 11/10/2014 12:00:00 AMLast Editorial Review: 11/10/2014 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - November 10, 2014 Category: Respiratory Medicine Source Type: news
Interstitial lung disease is a significant risk factor for lung inflammation
(International Association for the Study of Lung Cancer) Pretreatment interstitial lung disease is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer patients treated with stereotactic body radiation therapy alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2014 Category: Global & Universal Source Type: news
Isolation of . from the Blood of a Patient with Interstitial Lung Disease
The genus Laceyella within the family Bacillaceae was proposed by Yoon et al. (1) in 2005 and was placed in the family Thermoactinomycetaceae by Matsuo et al. (2) in 2006. Members of the genus Laceyella were initially considered to belong in the genus Thermoactinomyces (also known as actinomycetes). When Yoon and colleagues (1) first proposed the genus Laceyella, only two species were known: Laceyella sacchari and Laceyella putidus, which were previously named Thermoactinomyces sacchari (Thermoactinomyces thalpophilus) and Thermoactinomyces putidus, respectively (1,3). (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - August 23, 2014 Category: Microbiology Authors: Shobha Parajuli, Raghava Potula, David Ciccolella, Allan L. Truant Tags: Case Report Source Type: news
RheumShorts: Fibromyalgia, Scleroderma, Spondylitis (CME/CE)
(MedPage Today) -- News in rheumatology this week included water therapy for fibromyalgia, Gleevec for the often-lethal interstitial lung disease in scleroderma, and a temporary setback for apremilast in ankylosing spondylitis. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 10, 2014 Category: Primary Care Source Type: news
Lung Disease in RA Common, Lethal
(MedPage Today) -- Patients with rheumatoid arthritis-associated interstitial lung disease tend to have a distinct clinical phenotype that includes older age, respiratory symptoms, and worse RA overall -- and are at substantial risk for early mortality, researchers reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 2, 2014 Category: Primary Care Source Type: news
Rituximab May Help in RA Lung Disease
LIVERPOOL (MedPage Today) -- Patients with rheumatoid arthritis who have interstitial lung disease (ILD) appeared to have a survival advantage if treated with rituximab rather than with a tumor necrosis factor (TNF) inhibitor, a researcher said here. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - April 30, 2014 Category: Geriatrics Source Type: news
InterMune® announces support for first ever European Patient Charter on idiopathic pulmonary fibrosis (IPF)
To mark international Rare Disease Day, InterMune has announced its support for the development of a European Patient Charter for people with idiopathic pulmonary fibrosis (IPF). IPF is an irreversible, progressive and ultimately fatal fibrotic interstitial lung disease,. IPF has a projected survival rate of only 20-40% after five years1, 2 making it more rapidly lethal than many cancers3, 4. The disease causes scarring of the lungs, irreversibly destroying normal lung architecture and hindering a person's ability to breathe. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 3, 2014 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news
Toxic inhalational injury-associated interstitial lung disease in children - Lee E, Seo JH, Kim HY, Yu J, Jhang WK, Park SJ, Kwon JW, Kim BJ, Do KH, Cho YA, Kim SA, Jang SJ, Hong SJ.
Interstitial lung disease in children (chILD) is a group of disorders characterized by lung inflammation and interstitial fibrosis. In the past recent years, we noted an outbreak of child in Korea, which is possibly associated with inhalation toxicity. Her... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - February 22, 2014 Category: Global & Universal Tags: Age: Infants and Children Source Type: news
